Dutch digital breast cancer screening: Implications for breast cancer care

European Journal of Public Health

Volumn 22, Issue 6, 2012, Pages 925-929

  Timmers, Johanna M ^a,b   Den Heeten, Gerard J ^b,c   Adang, Eddy M ^a   Otten, Johannes D ^a   Verbeek, André L ^a,b   Broeders, Mireille J ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b 2 Dutch National Expert and Training Centre for Breast Cancer Screening   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BIOPSY; BREAST TUMOR; COST BENEFIT ANALYSIS; EARLY DIAGNOSIS; ECONOMICS; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; MAMMOGRAPHY; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MORTALITY; NETHERLANDS; OUTCOME ASSESSMENT; PATIENT REFERRAL; PREDICTIVE VALUE; STATISTICS; SURVIVAL RATE;

AGED; BIOPSY; BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NETHERLANDS; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PROGRAM EVALUATION; REFERRAL AND CONSULTATION; SURVIVAL RATE;

EID: 84870542530     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckr170     Document Type: Article

References (36)

1. Klabunde CN, Ballard-Barbash R. Evaluating Population-Based Screening Mammography Programs Internationally. Semin Breast Dis 2007;10:102-7. (Pubitemid 350166989)
2. Nystrom L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography:overview of Swedish randomised trials. Lancet 1993;341:973-78. (Pubitemid 23109165)
3. Nystrom L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002;359:909-19. (Pubitemid 34246378)
4. Fracheboud J, de Koning HJ, Beemsterboer PM, et al. Nation-wide breast cancer screening in The Netherlands: results of initial and subsequent screening 1990-1995. National Evaluation Team for Breast Cancer Screening. Int J Cancer 1998;75:694-98.
5. Dutch Association of Comprehensive Cancer Centres [VIKC]. Tables. Available at: www. ikcnet.nl. 2010. Dutch Association of Comprehensive Cancer Centres [VIKC] [date last accessed 1 December 2010].
6. Statistics Netherlands. Access to StatLine: make your own tables. Statistics Netherlands. Available at: http://www.cbs.nl/nl-NL/menu/cijfers/ statline/zelf-tabellen-maken/default. htm [date last accessed 1 December 2010].
7. National Evaluation Team for Breast Cancer Screening. National evaluation of breast cancer screening in the Netherlands, 1990-2007. Rotterdam: NETCB, 2009.
8. Elmore JG, Nakano CY, Koepsell TD, et al. International variation in screening mammographyinterpretations in community-based programs. J Natl Cancer Inst 2003;95:1384-93. (Pubitemid 37220458)
9. Lynge E, Olsen AH, Fracheboud J, Patnick J. Reporting of performance indicators of mammography screening in Europe. Eur J Cancer Prev 2003;12:213-22. (Pubitemid 36686748)
10. Yankaskas BC, Klabunde CN, ncelle-Park R, et al. International comparison of performance measures for screening mammography: can it be done? J Med Screen 2004;11:187-93. (Pubitemid 40006742)
11. National Evaluation Team for Breast Cancer Screening. National Evaluation of Breast Cancer Screening in the Netherlands, Preliminary Results 2009. Rotterdam: NETB, 2011.
12. Otten JD, Karssemeijer N, Hendriks JH, et al. Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators. J Natl Cancer Inst 2005;97:748-54. (Pubitemid 40872381)
13. Henselmans I, Sanderman R, Smink A, et al. The sooner, the better? Psychological consequences of waiting in breast disease clinics. Ned Tijdschr Geneeskd 2010;154:B491.
14. Van der Steeg AF, Keyzer-Dekker CM, de VJ, Roukema JA. Effect of abnormal screening mammogram on quality of life. Br J Surg 2010;98:537-42.
15. Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 2005;353:1773-83. (Pubitemid 41549889)
16. Bick U, Diekmann F. Digital mammography: what do we and what don't we know? Eur Radiol 2007;17:1931-42. (Pubitemid 47097450)
17. Bluekens A, Karssemeijer N, Beijereinck D, et al. Consequences of digital mammography in population-based breast cancer screening: initial changes and long term impact on referral rates. Eur Radiol 2010;20:2067-73.
18. Otten JD, van Dijck JA, Peer PG, et al. Long term breast cancer screening in Nijmegen, The Netherlands: the nine rounds from 1975-92. J Epidemiol Community Health 1996;50:353-58. (Pubitemid 26237094)
19. Heddson B Ronnow K Olsson M Miller D. Digital versus screen-film mammography a Retrospective Comparison In A Population-based Screening Program. Eur J Radiol 2007;64419-25 (Pubitemid 350116481)
20. Domingo L, Romero A, Belvis F, et al. Differences in radiological patterns, tumour characteristics and diagnostic precision between digital mammography and screen-film mammography in four breast cancer screening programmes in Spain. Eur Radiol 2011;21:2020-28.
21. Vinnicombe S, Pinto Pereira SM, McCormack VA, et al. Full-field digital versusscreen-film mammography: comparison within the UK breast screening program and systematic review of published data. Radiology 2009;251:347-58.
22. Del Turco MR, Mantellini P, Ciatto S, et al. Full-field digital versus screen-film mammography: comparative accuracy in concurrent screening cohorts. AJR Am J Roentgenol 2007;189:860-66. (Pubitemid 47479768)
23. Hambly NM, McNicholas MM, Phelan N, et al. Comparison of digital mammography and screen-film mammography in breast cancer screening: a review in the Irish breast screening program. AJR Am J Roentgenol 2009;193:1010-18.
24. Juel IM, Skaane P, Hoff SR, et al. Screen-film mammography versus full-field digital mammography in a population-based screening program: the sogn and fjordane study. Acta Radiol 2010;51:962-68.
25. Holland R, Rijken HJ, Hendriks JH. The Dutch population-based mammography screening: 30-years experience. Breast Care 2007;2:12-18. (Pubitemid 46364551)
26. Fracheboud J, de Koning HJ, Boer R, et al. Nationwide breast cancer screening programme fully implemented in The Netherlands. Breast 2001;10:6-11. (Pubitemid 32124124)
27. Karssemeijer N, Bluekens AM, Beijerinck D, et al. Breast cancer screening results 5 years after introduction of digital mammography in a population-based screening program. Radiology 2009;253:353-58.
28. Nationaal Borstkanker Overleg Nederland (NABON). Guidelines for screening, diagnosis and treatment of mamma carcinoma. Dutch Institute for Healthcare Improvement (CBO), 2008.
29. Duijm LE, Groenewoud JH, Koning HJ, et al. Delayed diagnosis of breast cancer in womenrecalled for suspicious screening mammography. Eur J Cancer 2008;45:774-81.
30. Dutch Healthcare Authority. Dutch Healthcare Authority, reimbursement rates. Availableat: www.nza.nl [date last accessed 29 November 2010].
31. SEO Economic research. Costs and benefits of healthcare renewal 2010.
32. Duijm LE, Groenewoud JH, Fracheboud J, et al. Utilization and cost of diagnostic imaging and biopsies following positive screening mammography in the southern breast cancer screening region of the Netherlands, 2000-2005. Eur Radiol 2008;18(11):2390-97.
33. Chubak J, Boudreau DM, Fishman PA, Elmore JG. Cost of breast-related care in the year following false positive screening mammograms. Med Care 2010;48:815-20.
34. Lee DW, Stang PE, Goldberg GA, Haberman M. Resource use and cost of diagnostic workup of women with suspected breast cancer. Breast J 2009;15:85-92.
35. Poplack SP, Carney PA, Weiss JE, et al. Screening mammography: costs and use of screening-related services. Radiology 2005;234:79-85. (Pubitemid 39658372)
36. National Institute for Public Health and the Environment (RIVM) and Erasmus MC. Cost of illness in the Netherlands. National Institute for Public Health and the Environment (RIVM), 2008.